Baystate Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$777K Buy
5,011
+714
+17% +$111K 0.06% 109
2023
Q3
$641K Buy
4,297
+225
+6% +$33.5K 0.05% 113
2023
Q2
$549K Sell
4,072
-280
-6% -$37.7K 0.05% 126
2023
Q1
$694K Buy
4,352
+133
+3% +$21.2K 0.06% 110
2022
Q4
$682K Sell
4,219
-80
-2% -$12.9K 0.06% 121
2022
Q3
$577K Buy
4,299
+35
+0.8% +$4.7K 0.06% 111
2022
Q2
$653K Sell
4,264
-68
-2% -$10.4K 0.06% 101
2022
Q1
$702K Sell
4,332
-67
-2% -$10.9K 0.06% 97
2021
Q4
$596K Buy
4,399
+399
+10% +$54.1K 0.05% 105
2021
Q3
$432K Buy
4,000
+287
+8% +$31K 0.04% 104
2021
Q2
$418K Buy
3,713
+198
+6% +$22.3K 0.04% 105
2021
Q1
$380K Buy
3,515
+31
+0.9% +$3.35K 0.04% 104
2020
Q4
$373K Sell
3,484
-1,471
-30% -$157K 0.04% 93
2020
Q3
$434K Buy
4,955
+266
+6% +$23.3K 0.05% 82
2020
Q2
$460K Buy
4,689
+422
+10% +$41.4K 0.05% 78
2020
Q1
$325K Buy
4,267
+25
+0.6% +$1.9K 0.04% 80
2019
Q4
$376K Buy
4,242
+881
+26% +$78.1K 0.05% 76
2019
Q3
$254K Sell
3,361
-718
-18% -$54.3K 0.03% 96
2019
Q2
$299K Buy
4,079
+28
+0.7% +$2.05K 0.04% 88
2019
Q1
$319K Sell
4,051
-208
-5% -$16.4K 0.04% 86
2018
Q4
$381K Buy
4,259
+27
+0.6% +$2.42K 0.06% 69
2018
Q3
$394K Buy
4,232
+410
+11% +$38.2K 0.07% 59
2018
Q2
$363K Buy
3,822
+20
+0.5% +$1.9K 0.05% 60
2018
Q1
$354K Hold
3,802
0.05% 56
2017
Q4
$405K Hold
3,802
0.06% 58
2017
Q3
$345K Sell
3,802
-227
-6% -$20.6K 0.06% 57
2017
Q2
$293K Sell
4,029
-1,109
-22% -$80.7K 0.05% 58
2017
Q1
$331K Buy
5,138
+1,796
+54% +$116K 0.06% 54
2016
Q4
$212K Buy
+3,342
New +$212K 0.04% 59
2013
Q3
Sell
-740
Closed -$31K 28
2013
Q2
$31K Buy
+740
New +$31K 0.02% 122